Guillain-Barré syndrome: celebrating a century

Freitas, Marcos R. G. de; Vidal, Cecília M.; Orsini, Marco

doi:10.1590/0004-282x20170093

Cited by 3 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has an acute or subacute beginning and is characterised by diversified levels of limb weakness or muscles with cranial nerve innervation, loss or diminished deep tendon reflexes and albuminocytologic dissociation . It is normally triggered by an acute infectious process and is a leading cause of flaccid paralysis in the world . The precise cause of the syndrome is not known, but 50–70% of the cases occur a week or two after a gastrointestinal or a respiratory infection or other immune stimulus that triggers an atypical autoimmune response that affects the peripheral nerves and their spinal roots .…”

Section: Introductionmentioning

confidence: 99%

Systematic review of factors associated with the development of Guillain–Barré syndrome 2007–2017: what has changed?

Wachira

Peixoto

Oliveira

2018

Tropical Med Int Health

View full text Add to dashboard Cite

Objective The objective of this study was to describe the factors associated with the development of Guillain–Barré syndrome, both infectious and non‐infectious, during and after the A(H1N1) influenza pandemic in 2009 and the recent Zika virus epidemic in the Americas. Method Systematic review of literature on factors associated with the development of the Guillain–Barré syndrome published between 2007 and 2017 listed in EBSCO, MEDLINE and LILACS databases. The quality of the studies was evaluated using the Newcastle Ottawa Scale. Results Thirty‐four articles met inclusion criteria and were selected for analysis. Their quality was considered good in relation to most of the items evaluated. Many aetiological agents had the results of association with Guillain–Barré syndrome, among them Campylobacter jejuni, influenza vaccine – both pandemic and seasonal vaccines, respiratory infection, gastrointestinal infection among others. The aetiological agents found are, in most part, the same reported prior to the study period. The association with surgeries, chikungunya virus (CHIKV), Zika virus and quadrivalent human papillomavirus vaccine stand out as new aetiological agents in the list of the various possible agents that trigger Guillain–Barré syndrome reported in the study period. There were no Brazilian studies identified during this period. Conclusions The results of the review reaffirmed C. jejuni as the major trigger of GBS, whereas the association of influenza vaccines and GBS is less clear; Zika virus infection in association with GBS was found in only one study.

show abstract

Section: Introductionmentioning

confidence: 99%

Systematic review of factors associated with the development of Guillain–Barré syndrome 2007–2017: what has changed?

Wachira

Peixoto

Oliveira

2018

Tropical Med Int Health

View full text Add to dashboard Cite

show abstract

“…In 1916, two French Neurologists Georges Charles Guillain and Jean Alexandre Barre and French Physiologist Andre Strohl reported an original paper encountered new syndrome in two soldiers with muscle weakness, absence of deep tendon reflexes and sensory impairment and described the key diagnosis of albumincytologic disassociation in the cerebrospinal fluid along with changes in electromyography and nerve conduction studies. Both patients were managed with massage therapy and Strychnine injection and showed clinical recovery after few months [1].…”

Section: Historymentioning

confidence: 99%

Guillain-Barre Syndrome and Miller Fisher Variant in Zika Virus Disease

Jadah¹

2021

Current Concepts in Zika Research

View full text Add to dashboard Cite

Guillain-Barre syndrome (GBS) is a serious neurological disorder associated with a rapid progressive ascending muscle paralysis, and it is the most common neurological autoimmune disorder that affects the peripheral nervous system, which is usually triggered by viral or bacterial infection. GBS is rare in children and characterized by rapid progressive onset ascending muscle weakness associated with pain and sensory dysfunction. Miller Fisher syndrome (MFS), a variant of GBS, is rare in pediatric population which is typically manifested by ataxic gait, ophthalmoplegia, and areflexia since it is rare in children. It is vitally important to early diagnose this condition and to initiate early treatment to prevent further complications and long-term morbidity. Since the outbreak of Zika virus, the incidence of GBS has been increased. Zika virus associated with autoimmune anti-ganglioside antibodies trigger which lead to GBS development. Zika virus infection should be strongly considered in patients who present with classical signs of Miller Fisher syndrome, especially travelers and residents from endemic areas.

show abstract

“…Approximately four decades later, in honor of its investigators, the disease received the name of Guillain-Barré syndrome (GBS). 1 GBS is a peripheral polyneuropathy, characterized by starting with acute bilateral and symmetric weakness of the limbs with reduced or absent myotactic reflexes. The disease is progressive and reaches its peak in between 12 hours and 28 days, followed by a plateau and subsequent improvement in survivors.…”

Section: Introductionmentioning

confidence: 99%